KCBS Radio (San Francisco) Interview on EpiPen 400% Price Increase
I was interviewed on KCBS on August 23, 2016 on Mylan’s 400% price increase of anti-allergy drug EpiPen.
Note: Last fall, Charlie Munger, Berkshire Hathaway’s vice chairman, described Valeant Pharmaceutical’s similar behavior of substantially increasing the prices of drugs that it had purchased from other pharmaceutical companies as “deeply immoral”.
